Key Insights

Highlights

Success Rate

67% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

5.3%

1 terminated out of 19 trials

Success Rate

66.7%

-19.8% vs benchmark

Late-Stage Pipeline

11%

2 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

67% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (9)
P 1 (2)
P 2 (1)
P 3 (2)

Trial Status

Recruiting7
Unknown4
Completed2
Not Yet Recruiting2
Active Not Recruiting1
Terminated1

Trial Success Rate

66.7%

Benchmark: 86.5%

Based on 2 completed trials

Clinical Trials (19)

Showing 19 of 19 trials
NCT06428448Phase 2RecruitingPrimary

Study to Evaluate the REMEDY SPECTRUM IM Spacer Nail in the Treatment of Ankle-Related Infections

NCT05495815Not ApplicableWithdrawnPrimary

Proper Duration of Suppressive Antibiotic Therapy After Debridement, Antibiotics, and Implant Retention

NCT06737809Not ApplicableRecruitingPrimary

IP-coated Revision Hip Implants

NCT07313215Not ApplicableRecruitingPrimary

Rifampin-combined Antibiotic Therapy for Staphylococcal PJI

NCT05640336Not ApplicableEnrolling By InvitationPrimary

Treatment of Acute Periprosthetic Joint Infection Comparing Single and Planned Double-Debridement Antibiotics and Implant Retention Followed by Chronic Antibiotic Suppression

NCT06268795RecruitingPrimary

A Diagnostic Test Accuracy Study Comparing Biopsy to Aspiration in Shoulder and Elbow Arthroplasty Revision Surgery (BASE Study)

NCT05084378Phase 3CompletedPrimary

Evaluation of Emerging New Treatments for Infection Prevention in Total Joint Replacement

NCT06942624Phase 1Not Yet RecruitingPrimary

Phage Therapy for the Treatment of a Chronic Enterococcus Faecium Periprosthetic Joint Infection

NCT06827041Phase 1Active Not RecruitingPrimary

Use of Phage Therapy for Treatment of a Periprosthetic Joint Infection

NCT06464770Not ApplicableRecruiting

Optimizing Infection Prophylaxis Prior to Shoulder Surgery

NCT06126614Phase 3RecruitingPrimary

Infection Prophylaxis in Total Joint Replacement

NCT06189885Not ApplicableNot Yet RecruitingPrimary

Preoperative Daptomycin Prophylaxis in Two-Stage Exchange Arthroplasty: A Prospective, Randomized, Double-Blinded Trial

NCT05320354UnknownPrimary

Diagnosis and Bacterial Identification of Periprosthetic Joint Infection With Microbial-ID

NCT04274517Not ApplicableTerminatedPrimary

Microbial Growth in Operative Splash Basins During Total Joint Arthroplasty

NCT05357287Not ApplicableUnknown

Closed Incisional Negative Pressure Wound Therapy in Post-surgical Wound Care of Patients With Periprosthetic Joint Infection

NCT05284318RecruitingPrimary

Prospective Cohort Study on Antibiotic Course and Efficacy After Two-stage Revision in PJI.

NCT03139539Not ApplicableCompletedPrimary

Intraoperative Microbial Contamination

NCT02868736UnknownPrimary

Clinical Validation of CD Diagnostics Synovasure PJI ELISA Test and Synovasure PJI Lateral Flow Test for Detection of Periprosthetic Joint Infection in Synovial Fluid

NCT02530229UnknownPrimary

Arthrocentesis Study

Showing all 19 trials

Research Network

Activity Timeline